IDVOther than small business
IDC (single-award IDV) VA797P14C0011BAUSCH & LOMB INCORPORATED
Overview
Award facts
- Orders under this IDV
- No orders recorded under this IDV.
- Period of performance
- From Jan 1, 2017
- Modifications
- 4
- Latest action Feb 2, 2017
- Contract type
- IDC (single-award IDV)
- PIID VA797P14C0011
Description of requirement
PRESERVISION AREDS 2 FORMULA AND PRESERVISION AREDS LUTEIN AWARD. BASE YEAR PLUS 2 ONE-YEAR OPTION PERIODS
Dates and value
- Award date
- Signed on Jul 22, 2014
- Ordering period ends
- Jul 31, 2017
- Ceiling
- Ceiling (single-award vehicle): $16,689,721
Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Feb 2, 2017. View on USAspending · Recipient on SAM.gov
Recipient
LocationROCHESTER, NY
UEILTHFBQUCMPU4
Business sizeOther than small businessSize at award, per the contracting officer
Organization typeCorporate not tax exempt
Parent companyVALEANT PHARMACEUTICALS INTERNATIONAL
Business types and certifications
For-profit organizationCorporation (not tax-exempt)Manufacturer of goods
Self-reported at the time of the action.
Agency and place
Awarding and funding
- Awarded by
- Department of Veterans Affairs
- NAC PHARMACEUTICALS 36P797
- Funded by
- Department of Veterans Affairs
- NAC PHARMACEUTICALS 36P797
Classification and competition
Classification
- Product or service (PSC)
- 6505DRUGS AND BIOLOGICALS (product)
Competition
- Extent competed
- Not competedC
- Reason not competed
- Only one source-other (FAR 6.302-1 other)ONE
- Solicitation procedures
- Only one sourceSSS
- Set-aside
- No set-aside used
- Contract pricing
- Firm fixed priceJ
- Offers received
- 1
Solicitation and notices
- Solicitation ID
- VA797P-14-R-0021(as reported)
Contract details
- Subcontracting plan
- Plan required - incentive not includedC
- Cost Accounting Standards clause
- Not applicable exempt from CASX
- Certified cost or pricing data
- No
- Commercial procedures
- Commercial itemA
- Government-furnished property
- Transaction does not use GFE/GFPN
- Bundled requirement
- Not a bundled requirementD
- Consolidated requirement
- No
- Undefinitized action (terms not final)
- No
- Multi-year contract
- No
Transaction history
Modification history
- Base award
- Jul 22, 2014
- Latest action
- Feb 2, 2017 — Other administrative actionModification P00004; administrative: no change in scope or value
- Latest substantive action
- Jul 13, 2016 — Option exercisedModification P00003
- Actions by type
- Base award1
- Option exercised2
- Other administrative action2
All contract data
All contract data
Every other field reported for this award, as of its latest reported action
Competition
- Evaluation preference
- No preference used
- Local area set-aside
- No
- Synopsized publicly (SAM.gov / FedBizOpps)
- Yes
- Simplified procedures for commercial items
- No
- A-76 (FAIR Act) action
- No
Socio-economic and policy
- Recovered materials and sustainability
- No clauses included and no sustainability includedC
- Clinger-Cohen Act planning (IT)
- No
- Walsh-Healey Act (materials and supplies)
- No
Place and origin
- Domestic or foreign entity
- U.S. owned businessA
Structure
- Award or IDV
- IDV
- IDV type
- IDCB
- Indefinite-delivery contract type
- Indefinite delivery / requirementsA
- Multiple or single award
- Single awardS
- Program acronym
- PHARM STANDARDIZATION
- Awarding agency code
- 3600
- Awarding sub-tier code
- 3600
- Contracting office code
- 36P797
- Transactions recorded under this award key
- 4
Funding
- Funding agency code
- 3600
- Funding sub-tier code
- 3600
- Funding office code
- 36P797